ZNF223 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.518600E-01
Normal-vs-Stage2
5.247800E-01
Normal-vs-Stage3
6.457900E-02
Normal-vs-Stage4
9.480200E-01
Stage1-vs-Stage2
4.996800E-01
Stage1-vs-Stage3
6.722400E-02
Stage1-vs-Stage4
7.938800E-01
Stage2-vs-Stage3
2.360200E-01
Stage2-vs-Stage4
4.225400E-01
Stage3-vs-Stage4
7.356000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.577400E-01
Normal-vs-AfricanAmerican
1.007380E-01
Normal-vs-Asian
9.404200E-01
Caucasian-vs-AfricanAmerican
3.375000E-01
Caucasian-vs-Asian
3.929400E-01
AfricanAmerican-vs-Asian
2.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.102800E-01
Normal-vs-Female
6.504000E-01
Male-vs-Female
3.928600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.998000E-01
Normal-vs-Age(41-60Yrs)
7.952600E-01
Normal-vs-Age(61-80Yrs)
4.221000E-01
Normal-vs-Age(81-100Yrs)
7.407800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.843000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.071200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.370200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.104980E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.803900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.238000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.043400E-01
Normal-vs-Daily Drinker
6.510400E-02
Normal-vs-Weekly Drinker
1.775190E-01
Normal-vs-Occasional Drinker
7.399800E-01
Normal-vs-Social Drinker
2.572600E-01
Non Drinker-vs-Daily Drinker
5.640800E-01
Non Drinker-vs-Weekly Drinker
5.545000E-01
Non Drinker-vs-Occasional Drinker
4.281900E-03
Non Drinker-vs-Social Drinker
6.513800E-01
Daily Drinker-vs-Weekly Drinker
8.695800E-01
Daily Drinker-vs-Occasional Drinker
3.322100E-03
Daily Drinker-vs-Social Drinker
2.988600E-01
Weekly Drinker-vs-Occasional Drinker
1.059740E-02
Weekly Drinker-vs-Social Drinker
3.687000E-01
Occasional Drinker-vs-Social Drinker
3.579600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.646000E-02
Normal-vs-Grade 2
2.297800E-02
Normal-vs-Grade 3
7.383000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.888000E-01
Grade 1-vs-Grade 3
8.126800E-01
Grade 1-vs-Grade 4
6.646000E-02
Grade 2-vs-Grade 3
4.808800E-01
Grade 2-vs-Grade 4
2.297800E-02
Grade 3-vs-Grade 4
7.383000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.176000E-02
Normal-vs-NonDiabetic
5.368400E-01
Diabetic-vs-NonDiabetic
1.167800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.250000E-01
Normal-vs-NoPancreatitis
4.131800E-01
Pancreatitis-vs-NoPancreatitis
4.138400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.259400E-01
Normal-vs-N1
3.911000E-01
N0-vs-N1
2.475400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.390600E-01
Normal-vs-TP53-NonMutant
5.727800E-01
TP53-Mutant-vs-TP53-NonMutant
7.589900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
